DocSym
β
Searchsearch
Search
(F18.8) Mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
More details coming soon
40 889 in individuals diagnosis mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders confirmed
1 802 deaths with diagnosis mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
4% mortality rate associated with the disease mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
Diagnosis mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders is diagnosed Men are 71.73% more likely than Women
35 110
Men receive the diagnosis mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
1 802 (5.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
5 779
Women receive the diagnosis mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders - Men aged 25-29 and Women aged 15-19
In Men diagnosis is most often set at age 0-5, 10-64, 70-79
Less common in men the disease occurs at Age 0-1, 5-9, 65-69, 80-95+Less common in women the disease occurs at Age 0-9, 45-49, 60-95+
In Women diagnosis is most often set at age 0-1, 10-44, 50-59
Disease Features mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
Absence or low individual and public risk
Mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders - what does this mean
Mental and behavioural disorders due to use of volatile solvents are caused by direct exposure to these substances, which can lead to cognitive impairment, mood disturbances, and other behavioural changes. these changes can be caused by the direct toxicity of the solvents, or the indirect effects of the solvents on the brain and nervous system. long-term exposure can lead to more severe mental and behavioural disorders.
What happens during the disease - mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders
The pathogenesis of mental and behavioural disorders due to the use of volatile solvents is likely due to the direct neurotoxic effects of the solvents on the brain, resulting in changes in neurotransmitter levels, changes in the structure and function of brain cells, and an overall disruption of the normal functioning of the brain. these changes can lead to a wide range of mental and behavioural disorders such as depression, anxiety, psychosis, and personality changes.
Clinical Pattern
A patient suffering from mental and behavioural disorders due to use of volatile solvents often presents with symptoms such as confusion, irritability, depression, anxiety, impaired concentration, memory loss, and disorientation. They may also have physical symptoms such as headaches, nausea, dizziness, and fatigue. In more severe cases, the patient may experience hallucinations, delusions, and even suicidal thoughts. It is important to seek medical help immediately if any of these symptoms are present.
How does a doctor diagnose
- Psychological evaluation
- Neuropsychological testing
- Physical exam
- Blood tests
- Urine tests
- Imaging tests (CT/MRI)
- Toxicology screening
- Psycho-social assessment
- Substance use history
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk and severity of mental and behavioural disorders due to the use of volatile solvents.
- Provide education and information about the risks of using volatile solvents.
- Encourage the use of protective clothing and equipment when using volatile solvents.
- Provide support and counselling to those affected by the use of volatile solvents.
- Provide medical monitoring and assessment of those affected by the use of volatile solvents.
- Encourage the use of non-volatile solvents where possible.
- Encourage the use of ventilation and air filtration systems when using volatile solvents.
- Provide access to mental health services for those affected by the use of volatile solvents.
- Provide access to substance abuse treatment services for those affected by the use of volatile solvents.
33 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Mental and behavioural disorders due to use of volatile solvents : other mental and behavioural disorders - Prevention
The best way to prevent mental and behavioural disorders due to use of volatile solvents is to avoid exposure to these substances altogether. if exposure is unavoidable, use proper ventilation, wear protective gear, and limit exposure time as much as possible. additionally, individuals should be aware of the signs and symptoms of these disorders and seek help immediately if they experience any of them.